Avalo Therapeutics (AVTX) Goodwill & Intangibles (2017 - 2026)

Avalo Therapeutics (AVTX) has 10 years of Goodwill & Intangibles data on file, last reported at $10.5 million in Q1 2026.

• Quarterly Goodwill & Intangibles changed 0.0% year-over-year to $10.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $10.5 million, changed 0.02% from the prior year.
• Goodwill & Intangibles steadied at $10.5 million in Q1 2026, from $10.5 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $14.4 million in Q1 2022 to a low of $10.5 million in Q4 2024.
• A 5-year average of $12.1 million and a median of $10.5 million in 2023 frame the typical range for Goodwill & Intangibles.
• Annual changes were most pronounced in 2023 — Goodwill & Intangibles declined 27.11% — and 2025, when it grew 0.02%.
• Tracing AVTX's Goodwill & Intangibles over 5 years: stood at $14.4 million in 2022, then decreased by 27.11% to $10.5 million in 2023, then slipped by 0.02% to $10.5 million in 2024, then climbed by 0.02% to $10.5 million in 2025, then changed by 0.0% to $10.5 million in 2026.
• The last three Goodwill & Intangibles figures came in at $10.5 million (Q1 2026), $10.5 million (Q4 2025), and $10.5 million (Q3 2025), per Business Quant data.